Viewing StudyNCT00100256



Ignite Creation Date: 2024-05-05 @ 11:40 AM
Last Modification Date: 2024-10-26 @ 9:11 AM
Study NCT ID: NCT00100256
Status: RECRUITING
Last Update Posted: 2022-11-07
First Post: 2004-12-27

Brief Title: Rhenium Re 188 P2045 in Patients With Lung Cancer Who Have Received or Refused to Receive Prior Chemotherapy
Sponsor: Andarix Pharmaceuticals
Organization: Andarix Pharmaceuticals

Conditions & Keywords Data

Conditions:
Name
Neoplasm Recurrence Local
Lung Neoplasms
Carcinoma Non-Small-Cell Lung
Carcinoma Small Cell
Keywords:
Name View
Disseminated or recurrent small cell lung cancer View
Advanced or recurrent stage IIIb or IV non small cell lung cancer View